Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MYRG | CRC |
|---|---|---|
| Price | $302.65 | $53.01 |
| Change today | ▼ 0.70% | ▲ 1.11% |
| Market cap | $4.71B | $4.71B |
| Return, 3 months | -27.8% | +4.6% |
| Return, year to date | +38.5% | +21.1% |
| Return, 1 year | +51.6% | +4.6% |
| P/E (TTM) | 28.7 | -42.4 |
| P/B | 6.2 | 1.4 |
| P/E percentile vs own 5y | – | 2nd |
| Dividend yield | – | 3.02% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +58.1% | +45.0% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 54 | 50 |
| 30-day volatility | 38.0% | 28.9% |
| Max drawdown, 1 year | -45.9% | -29.2% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
